Please refer to the attachment.
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Themis Medicare reported a standalone net loss of Rs. 1,418.55 Lakhs for FY2026 versus a profit of Rs. 2,392.15 Lakhs in FY2025. Revenue from operations declined to Rs. 34,223.55 Lakhs from Rs. 40,551.16 Lakhs, representing a 15.6% drop. On a consolidated basis, the company posted a marginal profit of Rs. 114.37 Lakhs (vs Rs. 2,983.28 Lakhs), helped by share of profit from associates and joint ventures of Rs. 1,404.84 Lakhs. Exceptional items included Rs. 86.53 Lakhs impact from new Labour Codes and Rs. 129.39 Lakhs write-off of investment in struck-off UK subsidiary. The Board recommended a dividend of Rs. 0.50 per share. Operating cash flow turned negative at Rs. 326.53 Lakhs compared to positive Rs. 3,471.01 Lakhs in the previous year.
The company swung to a loss on standalone basis due to revenue decline and exceptional items, though consolidated results remained marginally profitable due to associate contributions. The negative operating cash flow and significant revenue contraction are concerning signals for shareholders.